You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
AstraZeneca
Colorcon
Moodys
Dow

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

BUTALBITAL AND ACETAMINOPHEN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Butalbital And Acetaminophen, and what generic alternatives are available?

Butalbital And Acetaminophen is a drug marketed by Granules Pharms, Mayne Pharma Inc, Cnty Line Pharms, Halsey, Larken Labs Inc, Mikart, Nexgen Pharma, and Watson Labs. and is included in nine NDAs.

The generic ingredient in BUTALBITAL AND ACETAMINOPHEN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

Drug patent expirations by year for BUTALBITAL AND ACETAMINOPHEN
Recent Clinical Trials for BUTALBITAL AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4
GlaxoSmithKlinePhase 3

See all BUTALBITAL AND ACETAMINOPHEN clinical trials

Pharmacology for BUTALBITAL AND ACETAMINOPHEN
Drug ClassBarbiturate

US Patents and Regulatory Information for BUTALBITAL AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules Pharms BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital CAPSULE;ORAL 213115-001 Nov 22, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
Mikart BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 207386-001 Nov 15, 2016 AA RX No No   Start Trial   Start Trial   Start Trial
Cnty Line Pharms BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 205120-001 Oct 30, 2015 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
AstraZeneca
Colorcon
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.